Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals.

Lack of antiviral treatment is associated with increased mortality, HCRU, and economic burden in older Medicare beneficiaries with seasonal influenza. Future research should investigate whether the choice of antivirals affects influenza burden.